TheStreet

Trevena Inc (NASDAQ: TRVN), a clinical-stage biopharmaceutical company that focuses on therapeutics that use an approach to target G protein coupled receptors (GPCRs), saw its shares plummet around 30 percent Tuesday morning despite a positive development in Phase 3 trials. Trevena announced...

The tricky thing about pharmaceuticals is that, in theory, they’re meant to write themselves out of the equation. True success — a world without disease — would also mean a world without drugs and a world without pharmaceuticals. When drug companies are successful, they cease to...

We’re looking at a whole new culture. For the first time in Super Bowl history, PepsiCo, Inc. (NYSE: PEP) will forgo ads for its hallmark can of Pepsi and instead push its sugar-free beverage line. “It’s got to start with consumer demand,” chief marketing officer Seth...

Macy's Inc (NYSE: M)'s stock plunged around 15 percent on Thursday and is within striking distance of its 52-week low of $29.94. Investors and traders heavily sold the stock after the company announced disappointing holiday sales numbers and news that it will close another 100 stores. Disappointing...

Halozyme Therapeutics, Inc. (NASDAQ: HALO) shares are trading higher by $1.31 at $12.00 in Thursday's session. The issue spiked to $17.045 in pre-market trading but has come nowhere near that level during the regular session. The catalyst for the brief rally was the announcement that a Phase 2...

An article on TheStreet.com reiterated a bear thesis for Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP), while quoting a source saying the phase II clinical trial data of resunab were “nowhere near as robust or convincing as the company claimed them to be.” Cantor Fitzgerald’...

Investors in Pioneer Natural Resources (NYSE: PXD) stock were hurt when oil prices sharply dropped in the afternoon session Thursday, following the offering of 5.25 million shares at $157.52 (3.1 percent lower than the previous close). In his analysis of Pioneer Natural Resources, TheStreet's Real...

Wal-Mart Stores, Inc. (NYSE: WMT) is gearing up for the next major battlefield and attract new customers with a major push into the private label segment. Private label products, also known as store brands, are products that simply contain a stores own name or brand. It offers consumers the...

Shares of Relypsa Inc (NASDAQ: RLYP) surged higher by more than 30 percent early Friday morning on no corporate news or rumors. According to the TheStreet'sAdam Feuerstein, Relypisa scored a "big win" on Friday after its chief rival AstraZeneca plc (ADR) (NYSE: AZN) confirmed the...

Shares of Abercrombie & Fitch Co. (NYSE: ANF) plummeted more than 17 percent on Thursday after the company reported a poorer-than-expected first-quarter print. The company said that it lost $0.59 per share in the first quarter on revenue of $685.5 million. Wall Street analysts were expecting...

Valeant Pharmaceuticals Intl Inc (NYSE: VRX) stock surged to 12.50 percent to $109.80 in Tuesday's afternoon trading session, following its new 20-year deal announcement to cut prices for Walgreens Boots Alliance Inc (NASDAQ: WBA). The drug deal comes six weeks after the company had cut ties with...

TheStreet's Brian Sozzi argued last week that McDonald's Corporation (NYSE: MCD) lags competitors in the spicy food trend – a mistake that may hurt its performance. At present, McDonald's is only testing a Spicy McChicken sandwich in select markets as a limited-time offer, according to McDonald's...

Jill Malandrino was recently a guest on #PreMarket Prep, a daily trading idea radio show hosted by Joel Elconin and Dennis Dick. Tune in to the daily broadcast live Monday-Friday at 8 a.m. ET here. TheStreet's OptionsProfits Product Development Manager Jill Malandrino told Benzinga's #PreMarket...